Polish computational chemistry outfit Molecule.one has raised $4.6 million to expand its quest to bring theoretical drug molecules to reality. Its machine learning systems predict the best ways to synthesize potentially valuable molecules, a crucial part of creating new drugs and treatments. Molecule.one went onstage at Disrupt SF 2019’s Startup Battlefield, where they explained the … Continue reading Molecule.one grows its drug synthesis AI platform with a $4.6M seed round